{"url_path":"/sec/neo/8-k/2026-07-20/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000045-index.html","accession_number":"0001077183-26-000045","cik":"0001077183","ticker":"NEO","issuer_name":"NEOGENOMICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000045-index.html","primary_entity_key":"0001077183","primary_entity_name":"NEOGENOMICS INC"},"word_count":112,"has_tables":true,"body_markdown":"Item 7.01Regulation FD Disclosure.\n\nOn June 20, 2026, NeoGenomics, Inc. (the “Company”) issued a press release in connection with the settlement agreement described in Item 8.01 below.\n\nThe information in Item 7.01 of this Current Report and in Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing."}